Good to see some other small players with cancer treatments are being given BTD:
Up until now, the FDA has reserved its new "breakthrough" designation for a Who's Who in drug development, with high-profile companies like J&J, Merck and Novartis touting their scores at the agency. But now the FDA has delivered the coveted designation to Durham, NC-based ScioDerm, a little-known start-up that just landed its Series A of $16 million. And its success is blazing a path others can follow.
Read more: Biotech upstart joins Big Pharma cast on high-profile 'breakthrough' stage - FierceBiotech http://www.fiercebiotech.com/story/biotech-upstart-joins-big-pharma-cast-high-profile-breakthrough-stage/2013-04-30#ixzz2edV0O1dG
- Forums
- ASX - By Stock
- prr could be blockbuster from 1 october
Good to see some other small players with cancer treatments are...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $537.4M |
Open | High | Low | Value | Volume |
37.0¢ | 38.3¢ | 36.5¢ | $1.060M | 2.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48648 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 13814 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 48648 | 0.365 |
7 | 164694 | 0.360 |
4 | 31498 | 0.355 |
7 | 161310 | 0.350 |
3 | 12221 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 13814 | 2 |
0.375 | 175836 | 7 |
0.380 | 137322 | 5 |
0.385 | 53062 | 4 |
0.390 | 197301 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online